The incidence of worsening impulse control disorders in the initiation of apomorphine therapy
et
01 juin 2024
À propos de cet article
Publié en ligne: 01 juin 2024
Pages: 45 - 48
DOI: https://doi.org/10.21307/ajon-2024-005
Mots clés
© 2024 David Tsui et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Apomorphine therapy was first discovered in the 19th century and became clinically available for use in 1980’s. Apomorphine therapy has been described as an underutilised therapy for Parkinson’s disease (The aim of this study was to determine the incidence of Impulse Control Disorders (ICD) using a clinician administered rating scale the ‘Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease Rating Scale’ (QUIP-RS). The results of this study were consistent with the current literature that was reviewed. We found that apomorphine therapy were unlikely to worsen ICD and the use of apomorphine infusion may even improve ICD. In addition, concomitant use of dopamine agonists was not likely to worsen ICD.